Skip to main content
Erschienen in: Acta Neuropathologica 5/2010

01.11.2010 | Case Report

Nodular bilateral amygdala degeneration in demented individuals

verfasst von: Aurelio Hernandez Lain, Andrew P. Lieberman, Rolf Pfannl, E. Tessa Hedley-Whyte

Erschienen in: Acta Neuropathologica | Ausgabe 5/2010

Einloggen, um Zugang zu erhalten

Abstract

Among more than 2,050 brains in our Alzheimer disease brain banks, we came across three brains with well-demarcated indurated white-yellow nodules in the amygdalas. Microscopically, these nodules were composed of numerous lipid-laden macrophages located in the central region surrounded by an eosinophilic hyaline-like material with minimal reactive gliosis in the periphery. Neurons within these lesions had a normal appearance but were moderately decreased in number. Beta-amyloid, tau and alpha-synuclein immunostaining revealed no abnormal deposits within the nodules. The three patients had long histories of dementia (one linked to a presenilin-1 mutation). The neuropathological diagnoses were Alzheimer disease in two of them and an unclassified tauopathy with argyrophilic grains in the third. In conclusion, the pathogenesis of these lesions is uncertain. We favor that the degeneration has some relationship to the underlying dementing disease, either secondary to deafferentation or an alteration in metabolic demand, perhaps related to the bi-directional anatomical and functional connections that exist between the amygdala and the hippocampus or less likely as a primary event.
Literatur
1.
Zurück zum Zitat Auer RN, Siesjö BK (1988) Biological differences between ischemia, hypoglycemia, and epilepsy. Ann Neurol 24:699–707CrossRefPubMed Auer RN, Siesjö BK (1988) Biological differences between ischemia, hypoglycemia, and epilepsy. Ann Neurol 24:699–707CrossRefPubMed
2.
Zurück zum Zitat Brashear HR, Godec MS, Carlsen J (1988) The distribution of neuritic plaques and acetylcholinesterase staining in the amygdala in Alzheimer’s disease. Neurology 38:1694–1699PubMed Brashear HR, Godec MS, Carlsen J (1988) The distribution of neuritic plaques and acetylcholinesterase staining in the amygdala in Alzheimer’s disease. Neurology 38:1694–1699PubMed
3.
Zurück zum Zitat Broks P, Young AW, Maratos EJ et al (1998) Face processing impairments after encephalitis: amygdala damage and recognition of fear. Neuropsychologia 36:59–70CrossRefPubMed Broks P, Young AW, Maratos EJ et al (1998) Face processing impairments after encephalitis: amygdala damage and recognition of fear. Neuropsychologia 36:59–70CrossRefPubMed
4.
Zurück zum Zitat De Martino B, Camerer CF, Adolphs R (2010) Amygdala damage eliminates monetary loss aversion. Proc Natl Acad Sci USA 107:3788–3792CrossRefPubMed De Martino B, Camerer CF, Adolphs R (2010) Amygdala damage eliminates monetary loss aversion. Proc Natl Acad Sci USA 107:3788–3792CrossRefPubMed
5.
Zurück zum Zitat Duyckaerts C, Derouesne C, Signoret JL, Gray F, Escourolle R, Castaigne P (1985) Bilateral and limited amygdalohippocampal lesions causing a pure amnesic syndrome. Ann Neurol 18:314–319CrossRefPubMed Duyckaerts C, Derouesne C, Signoret JL, Gray F, Escourolle R, Castaigne P (1985) Bilateral and limited amygdalohippocampal lesions causing a pure amnesic syndrome. Ann Neurol 18:314–319CrossRefPubMed
6.
Zurück zum Zitat French SJ, Hailstone JC, Totterdell S (2003) Basolateral amygdala efferents to the ventral subiculum preferentially innervate pyramidal cell dendritic spines. Brain Res 981:160–167CrossRefPubMed French SJ, Hailstone JC, Totterdell S (2003) Basolateral amygdala efferents to the ventral subiculum preferentially innervate pyramidal cell dendritic spines. Brain Res 981:160–167CrossRefPubMed
7.
Zurück zum Zitat Hamada T, McLean WH, Ramsay M et al (2002) Lipoid proteinosis maps to 1q21 and is caused by mutations in the extracellular matrix protein 1 gene (ECM1). Hum Mol Genet 11:833–840CrossRefPubMed Hamada T, McLean WH, Ramsay M et al (2002) Lipoid proteinosis maps to 1q21 and is caused by mutations in the extracellular matrix protein 1 gene (ECM1). Hum Mol Genet 11:833–840CrossRefPubMed
8.
Zurück zum Zitat Hardy JA, Mann DM, Wester P, Winblad B (1986) An integrative hypothesis concerning the pathogenesis and progression of Alzheimer’s disease. Neurobiol Aging 7:489–502CrossRefPubMed Hardy JA, Mann DM, Wester P, Winblad B (1986) An integrative hypothesis concerning the pathogenesis and progression of Alzheimer’s disease. Neurobiol Aging 7:489–502CrossRefPubMed
9.
Zurück zum Zitat Herzog AG, Kemper TL (1980) Amygdaloid changes in aging and dementia. Arch Neurol 37:625–629PubMed Herzog AG, Kemper TL (1980) Amygdaloid changes in aging and dementia. Arch Neurol 37:625–629PubMed
10.
Zurück zum Zitat Kromer Vogt LJ, Hyman BT, Van Hoesen GW, Damasio AR (1990) Pathological alterations in the amygdala in Alzheimer’s disease. Neuroscience 37:377–385CrossRefPubMed Kromer Vogt LJ, Hyman BT, Van Hoesen GW, Damasio AR (1990) Pathological alterations in the amygdala in Alzheimer’s disease. Neuroscience 37:377–385CrossRefPubMed
11.
Zurück zum Zitat Meenan FO, Bowe SD, Dinn JJ et al (1978) Lipoid proteinosis; a clinical, pathological and genetic study. Q J Med 47:549–561PubMed Meenan FO, Bowe SD, Dinn JJ et al (1978) Lipoid proteinosis; a clinical, pathological and genetic study. Q J Med 47:549–561PubMed
12.
Zurück zum Zitat Meyer A, Beck E, Shepherd M (1955) Unusually severe lesions in the brain following status epilepticus. J Neurol Neurosurg Psychiatry 18:24–33CrossRefPubMed Meyer A, Beck E, Shepherd M (1955) Unusually severe lesions in the brain following status epilepticus. J Neurol Neurosurg Psychiatry 18:24–33CrossRefPubMed
13.
Zurück zum Zitat Mirra SS, Heyman A, McKeel D et al (1991) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 41:479–486PubMed Mirra SS, Heyman A, McKeel D et al (1991) The Consortium to Establish a Registry for Alzheimer’s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer’s disease. Neurology 41:479–486PubMed
14.
Zurück zum Zitat Newell KL, Hyman BT, Growdon JH, Hedley-Whyte ET (1999) Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer Disease. J Neuropathol Exp Neurol 58:1147–1155CrossRefPubMed Newell KL, Hyman BT, Growdon JH, Hedley-Whyte ET (1999) Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer Disease. J Neuropathol Exp Neurol 58:1147–1155CrossRefPubMed
15.
Zurück zum Zitat Saunders RC, Rosene DL (1988) A comparison of the efferents of the amygdala and the hippocampal formation in the rhesus monkey. I. Convergence in the entorhinal, prorhinal, and perirhinal cortices. J Comp Neurol 271:153–184CrossRefPubMed Saunders RC, Rosene DL (1988) A comparison of the efferents of the amygdala and the hippocampal formation in the rhesus monkey. I. Convergence in the entorhinal, prorhinal, and perirhinal cortices. J Comp Neurol 271:153–184CrossRefPubMed
16.
Zurück zum Zitat Saunders RC, Rosene DL, Van Hoesen GW (1988) Comparison of the efferents of the amygdala and the hippocampal formation in the rhesus monkey. II. Reciprocal and non-reciprocal connections. J Comp Neurol 271:185–207CrossRefPubMed Saunders RC, Rosene DL, Van Hoesen GW (1988) Comparison of the efferents of the amygdala and the hippocampal formation in the rhesus monkey. II. Reciprocal and non-reciprocal connections. J Comp Neurol 271:185–207CrossRefPubMed
17.
Zurück zum Zitat Scott SA, DeKosky ST, Scheff SW (1991) Volumetric atrophy of the amygdala in Alzheimer’s disease: quantitative serial reconstruction. Neurology 41:351–356PubMed Scott SA, DeKosky ST, Scheff SW (1991) Volumetric atrophy of the amygdala in Alzheimer’s disease: quantitative serial reconstruction. Neurology 41:351–356PubMed
18.
Zurück zum Zitat Siebert M, Markowitsch HJ, Bartel P (2003) Amygdala, affect and cognition: evidence from 10 patients with Urbach-Wiethe disease. Brain 126:2627–2637CrossRefPubMed Siebert M, Markowitsch HJ, Bartel P (2003) Amygdala, affect and cognition: evidence from 10 patients with Urbach-Wiethe disease. Brain 126:2627–2637CrossRefPubMed
19.
Zurück zum Zitat Smith AP, Stephan KE, Rugg MD, Dolan RJ (2006) Task and content modulate amygdala-hippocampal connectivity in emotional retrieval. Neuron 49:631–638CrossRefPubMed Smith AP, Stephan KE, Rugg MD, Dolan RJ (2006) Task and content modulate amygdala-hippocampal connectivity in emotional retrieval. Neuron 49:631–638CrossRefPubMed
20.
Zurück zum Zitat Vereecken TH, Vogels OJ, Nieuwenhuys R (1994) Neuron loss and shrinkage in the amygdala in Alzheimer’s disease. Neurobiol Aging 15:45–54CrossRefPubMed Vereecken TH, Vogels OJ, Nieuwenhuys R (1994) Neuron loss and shrinkage in the amygdala in Alzheimer’s disease. Neurobiol Aging 15:45–54CrossRefPubMed
21.
Zurück zum Zitat Volpe BT, Petito CK (1985) Dementia with bilateral medial temporal lobe ischemia. Neurology 35:1793–1797PubMed Volpe BT, Petito CK (1985) Dementia with bilateral medial temporal lobe ischemia. Neurology 35:1793–1797PubMed
22.
Zurück zum Zitat Vonsattel JPG, Aizawa H, Ge P et al (1995) An improved approach to prepare human brains for research. J Neuropathol Exp Neurol 54:42–56CrossRefPubMed Vonsattel JPG, Aizawa H, Ge P et al (1995) An improved approach to prepare human brains for research. J Neuropathol Exp Neurol 54:42–56CrossRefPubMed
Metadaten
Titel
Nodular bilateral amygdala degeneration in demented individuals
verfasst von
Aurelio Hernandez Lain
Andrew P. Lieberman
Rolf Pfannl
E. Tessa Hedley-Whyte
Publikationsdatum
01.11.2010
Verlag
Springer-Verlag
Erschienen in
Acta Neuropathologica / Ausgabe 5/2010
Print ISSN: 0001-6322
Elektronische ISSN: 1432-0533
DOI
https://doi.org/10.1007/s00401-010-0745-3

Weitere Artikel der Ausgabe 5/2010

Acta Neuropathologica 5/2010 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.